Semax

weak data

Also seen as: NA-Semax, Na-semax-amide

The Dose Guy’s verdict

Sep 1, 2026
3 sources

Semax is the best-supported nootropic peptide on this shelf, and that shelf is thin. Russian neurologists have run it for stroke recovery for decades, it clearly does something to BDNF and neural signaling, and the side profile is about as gentle as nootropic peptides get. No controlled trial has ever tested it for cognition in a healthy person, and no formal safety study exists, so the usual caveats apply. But if you are going to pick one compound from this category to try, semax is where I would start.

Would I take it?Caution, but the best-supported bet on a thin shelf.

What it is

A short synthetic peptide built from a fragment of ACTH, the pituitary hormone that drives your cortisol response. Semax raises BDNF, the growth factor that strengthens connections between neurons, particularly in the hippocampus. In rodent and isolated-neuron work it also nudges serotonin metabolism and modulates GABA signaling, which may explain why users report both a focus lift and a calm, even-keeled edge rather than the push of a stimulant. That mechanism story is animal data, not human confirmation, but the subjective reports line up.

You run it intranasally and it reaches the brain fast, but it degrades even faster, so people dose it multiple times a day. On the nootropic shelf it sits near noopept and cerebrolysin, the other Russian neuro-compounds with actual clinical history, but semax is the least invasive of the group: a nasal spray versus injections or a sublingual tablet.

What the research shows

The human evidence is real but pointed at disease, not enhancement. All of it comes from Russian stroke work, and none of it tested healthy cognition.

In 110 post-stroke patients, two 10-day semax courses at 6000 mcg/day raised plasma BDNF and improved the speed and final outcome of Barthel index recovery.Zh Nevrol Psikhiatr 2018 · clinical · n=110

In acute ischemic stroke, 30 semax-treated patients showed faster regression of neurological deficits, especially motor disorders, compared with 80 conventional-therapy controls.controlled study 1997 · n=30 vs 80

In healthy volunteers, intranasal 1% semax shifted default-mode-network activity in the medial frontal cortex within 20 minutes. The one imaging signal in a normal brain, and notably at the higher concentration.Bull Exp Biol Med 2018 · fMRI · n=24

No randomized controlled trial has tested semax for memory, attention, or cognition in healthy humans. The entire healthy-cognition case rests on mechanism, the stroke data, and years of firsthand reports.as of Aug 2026

Realistic protocols

Semax is a nasal spray, dosed two or three times a day. The standard solution is 0.1%, and each spray delivers roughly 50 to 100 mcg depending on the bottle. Most people start with one spray per nostril, two to three times daily, landing somewhere around 200 to 600 mcg/day. A low dose that works is winning, not underdosing. The 1% solution exists, and the only healthy-brain imaging signal on the sheet used 1% semax, but start with the weaker concentration and see what you notice before considering the step up.

Cycles of two to four weeks on, then a break of equal length, are the standard pattern. Most users report the subjective lift plateaus rather than builds, so cycling keeps the signal fresh. No food interaction matters, and there is no documented issue with alcohol. The practical note is storage: semax degrades at room temperature, so keep the vial refrigerated and use it within a few weeks of opening.

Start200–600 mcg/dayIntranasal 0.1%, split across 2–3 doses. Stay here if you feel it.

If the effect fades1% solutionMore mcg per spray. Step up only when the low dose stops delivering.

Cycle2–4 weeks onThen a break of equal length. The lift plateaus, so cycling keeps it useful.

Side effects

One of the gentler profiles on this shelf, but gentle is not silent:

commonNasal irritation, mild dryness, or a brief metallic taste after the spray. Resolves in minutes.

anecdotalHeightened emotionality or vivid dreams in the first week. Most users say it fades.

anecdotalOccasional reports of hair shedding with prolonged use, possibly BDNF-related. Persistent in forums, unconfirmed in any study.

unknownNo human trial has ever quantified adverse events or measured long-term safety. Decades of Russian clinical use is reassuring, but the formal data simply does not exist.